Quince Therapeutics, Inc. (QNCX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.36B |
| Enterprise Value | 3.37B |
| P/E Ratio | -0.13 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.02 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.24 |
| Return On Equity | 18.23 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -142,000 |
| EBITDA | -80.62M |
| Net Income | -83.98M |
| Diluted EPS | -336 |
| Total Cash | 18.16M |
| Total Cash/Share | 72.51 |
| Total Debt | 406,000 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 2.92 |
| Book Value Per Share | 62.57 |
| 52-Week Change | -94.49 |
| 52-Week High | 910 |
| 52-Week Low | 15.1 |
| Moving Average 50 Days | 22.29 |
| Moving Average 200 Days | 250.34 |
| Average Volume | 233,927 |
| Shares Outstanding | 278,408 |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 30, 2026 |